Means Investment CO. Inc. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,087 shares of the healthcare conglomerate’s stock after buying an additional 137 shares during the quarter. Means Investment CO. Inc.’s holdings in UnitedHealth Group were worth $1,520,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in the company. FMR LLC raised its holdings in shares of UnitedHealth Group by 0.6% during the 4th quarter. FMR LLC now owns 52,565,986 shares of the healthcare conglomerate’s stock valued at $18,433,841,000 after purchasing an additional 295,642 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in UnitedHealth Group by 5.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 38,003,233 shares of the healthcare conglomerate’s stock worth $13,318,678,000 after purchasing an additional 1,881,407 shares during the last quarter. Alliancebernstein L.P. grew its position in UnitedHealth Group by 5.2% in the 4th quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock worth $4,027,639,000 after purchasing an additional 569,142 shares during the last quarter. Norges Bank acquired a new stake in UnitedHealth Group in the 4th quarter worth $3,397,896,000. Finally, Bank of New York Mellon Corp grew its position in UnitedHealth Group by 2.4% in the 4th quarter. Bank of New York Mellon Corp now owns 8,858,179 shares of the healthcare conglomerate’s stock worth $3,106,385,000 after purchasing an additional 207,865 shares during the last quarter. Institutional investors and hedge funds own 86.03% of the company’s stock.
Several analysts have recently weighed in on the stock. Truist lifted their target price on shares of UnitedHealth Group from $400.00 to $420.00 in a research report on Tuesday, January 5th. Barclays reissued a “buy” rating and set a $405.00 price target on shares of UnitedHealth Group in a report on Sunday, January 17th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of UnitedHealth Group from $404.00 to $409.00 and gave the stock a “buy” rating in a research note on Thursday, January 21st. Bank of America reaffirmed a “buy” rating and issued a $415.00 target price on shares of UnitedHealth Group in a research note on Thursday, January 21st. Finally, SVB Leerink boosted their target price on shares of UnitedHealth Group from $378.00 to $390.00 and gave the stock an “outperform” rating in a research note on Monday, December 14th. Five investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $387.82.
UNH traded up $0.44 during trading hours on Thursday, hitting $366.08. 31,235 shares of the company’s stock were exchanged, compared to its average volume of 3,420,935. UnitedHealth Group Incorporated has a 1-year low of $246.26 and a 1-year high of $380.50. The stock’s 50-day moving average is $351.44 and its two-hundred day moving average is $339.34. The stock has a market cap of $346.06 billion, a price-to-earnings ratio of 21.00, a PEG ratio of 1.55 and a beta of 0.74. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.59.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 19th. The healthcare conglomerate reported $2.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.39 by $0.13. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business had revenue of $65.47 billion during the quarter, compared to analysts’ expectations of $64.98 billion. During the same quarter in the prior year, the company posted $3.90 earnings per share. The firm’s revenue was up 7.5% on a year-over-year basis. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.37%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.09%.
In related news, CAO Thomas E. Roos sold 619 shares of the firm’s stock in a transaction that occurred on Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total value of $200,494.10. Following the completion of the transaction, the chief accounting officer now owns 31,908 shares in the company, valued at approximately $10,335,001.20. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Richard T. Burke sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, March 15th. The shares were sold at an average price of $353.32, for a total transaction of $1,413,280.00. Following the completion of the transaction, the director now owns 153,953 shares of the company’s stock, valued at approximately $54,394,673.96. The disclosure for this sale can be found here. Insiders sold 9,619 shares of company stock worth $3,292,774 over the last 90 days. 0.80% of the stock is currently owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Featured Story: What is the Shanghai Stock Exchange Composite Index?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.